China · Delayed Price · Currency is CNY Beijing Aosaikang Pharmaceutical Company Description
Beijing Aosaikang Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of active pharmaceutical ingredients and formulations in China.
It also offers digestive health products, which include pump inhibitors suitable for various digestive tract-related diseases, such as peptic ulcers, reflux esophagitis, and upper gastrointestinal bleeding; and anti-tumor products, including the treatment of non-small cell lung cancer, colorectal cancer, and breast cancer, encompassing targeted therapy, chemotherapy, endocrine therapy, and adjuvant medications.
In addition, the company provides anti-infective products comprising a product defense line against bacterial and invasive fungal infections; and the chronic disease field focusing on chronic diseases requiring long-term management consisting of diabetes, osteoarthritis, thrombocytopenia, and iron overload.
Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 1996 and is based in Nanjing, China.
| Country | China |
| Founded | 1996 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 799 |
| CEO | Jingfei Ma |
Contact Details
Address: Jiangning Science Park Nanjing, 211112 China | |
| Phone | 86 25 5216 9999 |
| Website | ask-pharm.com |
Stock Details
| Ticker Symbol | 002755 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100001X92 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jingfei Ma | GM and Director |
| Tao Han | Chief Financial Officer and Head of Accounting Department |
| Xiangfeng Chen | Deputy GM and Non-Independent Director |